世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2015年
41期
57-57,59
,共2页
氟西汀%认知行为%抑郁症
氟西汀%認知行為%抑鬱癥
불서정%인지행위%억욱증
fluoxetine%cognitive behavior%depression
目的:探讨认知行为疗法与氟西汀联合对儿童及青少年抑郁症治疗的临床疗效。方法选择我院2013年4月至2015年1月收治的儿童及青少年(12~18岁)抑郁症患者68例为研究对象,随机分为对照组34例,单用氟西汀治疗,观察组34例,采取认知行为疗法与氟西汀联合治疗,对两组患者治疗后效果进行分析。结果两组患者治疗前的 Hrsd 评分无差异,经治疗后,观察组 Hrsd 评分明显较对照组低,差异存在统计学意义(P<0.05);观察组不良反应发生率为11.76%,明显较对照组29.41%低,差异有统计学意义(P<0.05)。结论儿童及青少年抑郁症采取认知行为疗法联合氟西汀治疗的疗效显著,且安全性高,能快速改善症状,值得推广。
目的:探討認知行為療法與氟西汀聯閤對兒童及青少年抑鬱癥治療的臨床療效。方法選擇我院2013年4月至2015年1月收治的兒童及青少年(12~18歲)抑鬱癥患者68例為研究對象,隨機分為對照組34例,單用氟西汀治療,觀察組34例,採取認知行為療法與氟西汀聯閤治療,對兩組患者治療後效果進行分析。結果兩組患者治療前的 Hrsd 評分無差異,經治療後,觀察組 Hrsd 評分明顯較對照組低,差異存在統計學意義(P<0.05);觀察組不良反應髮生率為11.76%,明顯較對照組29.41%低,差異有統計學意義(P<0.05)。結論兒童及青少年抑鬱癥採取認知行為療法聯閤氟西汀治療的療效顯著,且安全性高,能快速改善癥狀,值得推廣。
목적:탐토인지행위요법여불서정연합대인동급청소년억욱증치료적림상료효。방법선택아원2013년4월지2015년1월수치적인동급청소년(12~18세)억욱증환자68례위연구대상,수궤분위대조조34례,단용불서정치료,관찰조34례,채취인지행위요법여불서정연합치료,대량조환자치료후효과진행분석。결과량조환자치료전적 Hrsd 평분무차이,경치료후,관찰조 Hrsd 평분명현교대조조저,차이존재통계학의의(P<0.05);관찰조불량반응발생솔위11.76%,명현교대조조29.41%저,차이유통계학의의(P<0.05)。결론인동급청소년억욱증채취인지행위요법연합불서정치료적료효현저,차안전성고,능쾌속개선증상,치득추엄。
Objective: to investigate the clinical effect of the combination of cognitive behavior therapy and fluoxetine in the treatment of depression in children and adolescents. Methods: in our hospital in april 2013 to 2015 to January in children and adolescents (12 to 18 years old) depression patients 68 cases as the object of study, were randomly divided into for 34 cases in the control group, treated with uoxetine alone, the observation group (34 cases), take the cognitive behavioral therapy and uoxetine, analysis on the effect after the treatment, the patients in the two groups. Results: no difference in Hrsd scores of two groups of patients before treatment, after treatment, the observation group HRSD score was signi cantly lower than that of the control group, the difference is statistically signi cant (P<0.05); to observe the adverse reactions of the two groups the incidence rate is 11.76%, obviously lower than that in the control group, 29.41% lower, the difference is statistically signi cant (P<0.05). Conclusion: the treatment of children and adolescents with depression by cognitive behavior therapy combined with uoxetine in the treatment of a signi cant effect, and the safety is high, can quickly improve the symptoms, it is worth promoting.